Literature DB >> 16674979

Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?

Josep Gamez1, Marc Corbera-Bellalta, Gisela Nogales, Nuria Raguer, Elena García-Arumí, Mercè Badia-Canto, E Lladó-Carbó, José Alvarez-Sabín.   

Abstract

BACKGROUND: SOD1 gene mutations are the most common identified cause of ALS, accounting for approximately 20% of familial ALS cases and around 4% of sporadic ALS cases. However, the prevalence of SOD1 varies in different ethnic groups. No previous epidemiological studies have been carried out in Catalonia.
OBJECTIVE: To determine the prevalence of SOD1 gene mutations in a Catalan ALS population, and to analyze the genotype-phenotype relationship.
MATERIALS AND METHODS: 30 different FALS pedigrees and 94 sporadic ALS patients were screened for SOD1 mutations using direct sequence analysis.
RESULTS: Five of the 30 FALS pedigrees (16.6%) carried a SOD1 mutant. The mutations identified in this group were G37R, D76V, S105L, I112M and N139H. Four SOD1 mutants (4.25%) were found in the sporadic ALS group (SALS). The overall frequency (FALS plus SALS) of SOD1 mutations in our series was 6.45%. In the SALS group, D90A was identified in a patient presenting the typical Scandinavian phenotype. A 53-year-old woman with no family history of ALS carried the N139H mutation. Two unrelated sporadic ALS cases carried the A140A SOD1 mutant.
CONCLUSIONS: The prevalence of the SOD1 mutation in FALS in Catalonia is similar to levels in other Mediterranean countries, but lower than those in reports studying the Belgian, Japanese, and Scottish populations. The prevalence of the SOD1 mutation was 4.25% in patients with no family history of ALS. These results may have significant repercussions on genetic counseling, and screening for the SOD1 mutation in sporadic ALS cases must therefore be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674979     DOI: 10.1016/j.jns.2006.03.006

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Brachial amyotrophic diplegia associated with the a140a superoxide dismutase 1 mutation.

Authors:  L Di Vito; D de Biase; A Pession; M Visani; R Liguori; S Zambito Marsala; V Leta; P De Carolis; V Donadio
Journal:  Neurogenetics       Date:  2013-08-16       Impact factor: 2.660

2.  Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.

Authors:  Maria Pia Giannoccaro; Anna Bartoletti-Stella; Silvia Piras; Annalisa Pession; Patrizia De Massis; Federico Oppi; Michelangelo Stanzani-Maserati; Elena Pasini; Simone Baiardi; Patrizia Avoni; Piero Parchi; Rocco Liguori; Sabina Capellari
Journal:  J Neurol       Date:  2017-06-15       Impact factor: 4.849

3.  The distinct genetic pattern of ALS in Turkey and novel mutations.

Authors:  Aslıhan Özoğuz; Özgün Uyan; Güneş Birdal; Ceren Iskender; Ece Kartal; Suna Lahut; Özgür Ömür; Zeynep Sena Agim; Aslı Gündoğdu Eken; Nesli Ece Sen; Pınar Kavak; Ceren Saygı; Peter C Sapp; Pamela Keagle; Yeşim Parman; Ersin Tan; Filiz Koç; Feza Deymeer; Piraye Oflazer; Haşmet Hanağası; Hakan Gürvit; Başar Bilgiç; Hacer Durmuş; Mustafa Ertaş; Dilcan Kotan; Mehmet Ali Akalın; Halil Güllüoğlu; Mehmet Zarifoğlu; Fikret Aysal; Nilgün Döşoğlu; Kaya Bilguvar; Murat Günel; Özlem Keskin; Tahsin Akgün; Hilmi Özçelik; John E Landers; Robert H Brown; A Nazlı Başak
Journal:  Neurobiol Aging       Date:  2015-01-10       Impact factor: 4.673

Review 4.  Decoding ALS: from genes to mechanism.

Authors:  J Paul Taylor; Robert H Brown; Don W Cleveland
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

5.  UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort.

Authors:  Jose Manuel Vidal-Taboada; Alan Lopez-Lopez; Maria Salvado; Laura Lorenzo; Cecilia Garcia; Nicole Mahy; Manuel J Rodríguez; Josep Gamez
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

6.  PFN1 mutations are also rare in the Catalan population with amyotrophic lateral sclerosis.

Authors:  Enrique Syriani; Candi Salvans; Maria Salvadó; Miguel Morales; Laura Lorenzo; Sonia Cazorla; Josep Gamez
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

Review 7.  Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.

Authors:  Robert Bowser; Martin R Turner; Jeremy Shefner
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

8.  High-Resolution Melting (HRM) Analysis of the Cu/Zn Superoxide Dismutase (SOD1) Gene in Japanese Sporadic Amyotrophic Lateral Sclerosis (SALS) Patients.

Authors:  Chizuru Akimoto; Mitsuya Morita; Naoki Atsuta; Gen Sobue; Imaharu Nakano
Journal:  Neurol Res Int       Date:  2011-04-12

9.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

10.  CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis.

Authors:  Alan Lopez-Lopez; Josep Gamez; Emilio Syriani; Miguel Morales; Maria Salvado; Manuel J Rodríguez; Nicole Mahy; Jose M Vidal-Taboada
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.